Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
Keywords: گیرنده فعال فعال پروکسیوم; Apolipoprotein; Atherosclerosis; Dyslipidaemia; Hypertriglyceridaemia; Insulin resistance; Peroxisome proliferator-activated receptor